Capricor Therapeutics Inc

Markets

-25.66% percent quarterly performance for Capricor Therapeutics Inc (CAPR) is not indicative of the underlying story

Steve Mayer

On Friday, Capricor Therapeutics Inc (NASDAQ: CAPR) opened lower -7.65% from the last session, before settling in for the closing ...

Analyst Insights

Capricor Therapeutics Inc (CAPR) with a beta value of 0.67 appears to be a promising investment opportunity.

Sana Meer

On Friday, Capricor Therapeutics Inc (NASDAQ: CAPR) was 8.74% up from the session before settling in for the closing price ...

News Daemon
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.